67184-0535-1 |
67184-0535 |
HUMAN PRESCRIPTION DRUG |
Decitabine |
decitabine |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20210412 |
N/A |
ANDA |
ANDA212826 |
Qilu Pharmaceutical Co., Ltd. |
DECITABINE |
50 mg/20mL |
1 VIAL in 1 CARTON (67184-0535-1) / 20 mL in 1 VIAL |
25021-219-20 |
25021-219 |
HUMAN PRESCRIPTION DRUG |
Decitabine |
Decitabine |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20231101 |
N/A |
ANDA |
ANDA212826 |
Sagent Pharmaceuticals |
DECITABINE |
50 mg/20mL |
1 VIAL in 1 CARTON (25021-219-20) / 20 mL in 1 VIAL |
68001-618-37 |
68001-618 |
HUMAN PRESCRIPTION DRUG |
Decitabine |
Decitabine |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20240503 |
N/A |
ANDA |
ANDA212826 |
BluePoint Laboratories |
DECITABINE |
50 mg/20mL |
1 VIAL in 1 CARTON (68001-618-37) / 20 mL in 1 VIAL |
70860-219-20 |
70860-219 |
HUMAN PRESCRIPTION DRUG |
Decitabine |
decitabine |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20210815 |
20241231 |
ANDA |
ANDA212826 |
Athenex Pharmaceutical Division, LLC. |
DECITABINE |
50 mg/20mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (70860-219-20) / 20 mL in 1 VIAL, SINGLE-DOSE |